Smith & Nephew (SNN) Receivables - Other (2012 - 2025)
Smith & Nephew (SNN) posted quarterly Receivables - Other of $138.0 million for Q4 2025, down 6.76% year-on-year from $148.0 million in Q4 2024, and down 6.76% on a QoQ basis from $148.0 million in Q4 2024.
Smith & Nephew (SNN) Receivables - Other (2012 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Receivables - Other for 14 consecutive years, with $138.0 million the latest figure, recorded in Q4 2025.
- Quarterly Receivables - Other fell 6.76% year-over-year to $138.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138.0 million (down 6.76% YoY) and the FY2025 annual result came in at $138.0 million, down 6.76% from the prior year.
- Receivables - Other declined to $138.0 million in Q4 2025 per SNN's latest filing, from $148.0 million in the prior quarter.
- Over the last five years, Receivables - Other for SNN reached as high as $148.0 million in Q4 2024 and fell as low as $95.0 million in Q4 2021.
- A 5-year average of $123.4 million and a median of $122.0 million in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2021 — Receivables - Other soared 9400.0% — and 2025, when it retreated 6.76%.
- Year by year, Receivables - Other stood at $95.0 million in 2021, then climbed by 20.0% to $114.0 million in 2022, then climbed by 7.02% to $122.0 million in 2023, then advanced by 21.31% to $148.0 million in 2024, then decreased by 6.76% to $138.0 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $138.0 million, $148.0 million, and $122.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.00 Mn |
| Dec 31, 2025 | 138.00 Mn |
| Dec 31, 2024 | 148.00 Mn |
| Dec 31, 2024 | 148.00 Mn |
| Dec 31, 2023 | 122.00 Mn |
| Dec 31, 2023 | 122.00 Mn |
| Dec 31, 2022 | 114.00 Mn |
| Dec 31, 2022 | 114.00 Mn |
| Dec 31, 2021 | 95.00 Mn |
| Dec 31, 2021 | 95.00 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Dec 31, 2020 | 1.00 Mn |
| Dec 31, 2019 | 124.00 Mn |
| Dec 31, 2019 | 124.00 Mn |
| Dec 31, 2018 | 107.00 Mn |
| Dec 31, 2018 | 107.00 Mn |
| Dec 31, 2017 | 92.00 Mn |
| Dec 31, 2017 | 92.00 Mn |
| Dec 31, 2016 | 76.00 Mn |
| Dec 31, 2016 | 76.00 Mn |